ReviewHealthcare (Basel, Switzerland)2025
Arthroscopy for Femoroacetabular Impingement in Athletes Versus Non-Athletes: Systematic Review and Meta-Analysis.
Review in Healthcare (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Arthroscopy versus mini-open surgery for femoroacetabular impingement : A systematic review of clinical outcomes.Orthopadie (Heidelberg, Germany) · 2026Pooled it
- Reliable enough to guide care? An umbrella review of hip arthroscopy meta-analyses 2020-2025.Journal of experimental orthopaedics · 2026Review
- High Rates of Return to American Football After Primary Hip Arthroscopy for Femoroacetabular Impingement: A 2-Year Minimum Follow-up.Orthopaedic journal of sports medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFemoroacetabular impingement (FAI) is a frequently observed hip condition among young, active individuals-especially athletes-that can result in pain, restricted mobility, and a heightened risk of osteoarthritis. Hip arthroscopy has increasingly become the preferred surgical approach for managing FAI due to its ability to alleviate symptoms and improve function. However, potential differences in outcomes between athletes and non-athletes have not been thoroughly investigated. This systematic review and meta-analysis compared arthroscopic management for FAI in athletes versus non-athletes. The outcomes of interest were patient-reported outcome measures (PROMs) and complications.
methodsPubMed, Web of Science, and Embase were systematically accessed until October 2024. The studies eligible were clinical investigations comparing athletes and non-athletes undergoing hip arthroscopy for FAI with a minimum follow-up of 24 months. The outcomes assessed included the Visual Analogue Scale (VAS), Hip Outcome Score for Activities of Daily Living (HOS-ADL), and the Hip Outcome Score-Sport-Specific Subscale (HOS-SSS). Data on reoperation rates and progression to total hip arthroplasty were also extracted. The ROBINS-I tool was used to assess the risk of bias, and meta-analyses were performed using Review Manager 5.3.
resultsThree comparative investigations, comprising 808 patients (165 athletes and 643 non-athletes), met the inclusion criteria. Baseline characteristics were similar across both groups. The analyses demonstrated no statistically significant differences in the PROMs (VAS:
conclusionHip arthroscopy for FAI appears to yield equivalent improvements in pain and functional outcomes for both athletes and non-athletes, with comparable complication rates at an approximate two-year follow-up. Despite the limited number of studies and a moderate risk of bias, the findings support the effectiveness of arthroscopic intervention across varying physical activity levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.